Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Bioadaptives (BDPT) Non Operating Income (2019 - 2025)

Historic Non Operating Income for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to -$113813.0.

  • Bioadaptives' Non Operating Income fell 23502.23% to -$113813.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $25055.0, marking a year-over-year increase of 10534.06%. This contributed to the annual value of -$297071.0 for FY2024, which is 3856.39% up from last year.
  • Per Bioadaptives' latest filing, its Non Operating Income stood at -$113813.0 for Q3 2025, which was down 23502.23% from $121305.0 recorded in Q2 2025.
  • In the past 5 years, Bioadaptives' Non Operating Income registered a high of $138337.0 during Q3 2021, and its lowest value of -$278011.0 during Q1 2021.
  • In the last 5 years, Bioadaptives' Non Operating Income had a median value of -$87968.0 in 2023 and averaged -$84665.7.
  • In the last 5 years, Bioadaptives' Non Operating Income skyrocketed by 113548.27% in 2021 and then tumbled by 2108123.08% in 2023.
  • Bioadaptives' Non Operating Income (Quarter) stood at -$36549.0 in 2021, then soared by 97.33% to -$975.0 in 2022, then crashed by 21081.23% to -$206517.0 in 2023, then skyrocketed by 83.32% to -$34449.0 in 2024, then plummeted by 230.38% to -$113813.0 in 2025.
  • Its last three reported values are -$113813.0 in Q3 2025, $121305.0 for Q2 2025, and $52012.0 during Q1 2025.